The WACC of Chinook Therapeutics Inc (KDNY) is 7.4%.
| Range | Selected | |
| Cost of equity | 8.30% - 11.40% | 9.85% |
| Tax rate | 2.20% - 2.40% | 2.30% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.6% - 8.2% | 7.4% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.96 | 1.17 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.30% | 11.40% |
| Tax rate | 2.20% | 2.40% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.6% | 8.2% |
| Selected WACC | 7.4% | |